Evorel Sequi
Patches
registration number
31/21.8.2/0538
What Evorel Sequi contains
EVOREL SEQUI is a combination of an Estradiol matrix type transdermal patch and an Estradiol/Norethisterone acetate matrix type transdermal patch (sequential regimen).
EVOREL SEQUI is a transdermal therapy comprising:
(a) 4 EVOREL 50, each containing 3,1 mg estradiol, formulated as 3,2 mg of Estradiol hemihydrate. Each EVOREL 50 patch delivers 50 μg of Estradiol per 24 hours.
(b) 4 EVOREL CONTI each containing 3,1 mg Estradiol formulated as 3,2 mg of Estradiol hemihydrate and 9,82 mg Norethisterone, formulated as 11,2 mg of Norethisterone acetate. Each EVOREL CONTI delivers 50 μg of Estradiol and 170 μg of Norethisterone acetate per 24 hours.
other ingredients
Adhesive: Acrylate vinylacetate copolymer, Guar gum
Backing film: Polyethylene terephthalate foil
Release liner: Siliconised polyethylene terephthalate foil which is removed before application.
Therapeutic classification
Progesterones with Estrogens.